Document 0787
 DOCN  M9650787
 TI    Successful treatment of cryptococcal meningitis with amphotericin B
       colloidal dispersion: report of four cases.
 DT    9605
 AU    Valero G; Graybill JR; Department of Medicine, University of Texas
       Health Science Center; at San Antonio 78284-7870, USA.
 SO    Antimicrob Agents Chemother. 1995 Nov;39(11):2588-90. Unique Identifier
       : AIDSLINE MED/96139567
 AB    Four patients with cryptococcal meningitis were treated with
       amphotericin B colloidal dispersion because of nephrotoxicity from prior
       treatment with conventional amphotericin B. The limited experience
       presented here suggests that amphotericin B colloidal dispersion is
       efficacious for the treatment of cryptococcal meningitis, despite being
       undetectable in cerebrospinal fluid, and offers a potential therapeutic
       alternative for patients who cannot tolerate conventional amphotericin
       B.
 DE    Amphotericin B/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/  *THERAPEUTIC
       USE  Antibiotics, Antifungal/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/
       *THERAPEUTIC USE  AIDS-Related Opportunistic Infections/DRUG THERAPY
       Case Report  Colloids  Diabetes Mellitus,
       Non-Insulin-Dependent/COMPLICATIONS  Heart Transplantation  Human
       Leukemia, Lymphocytic, Acute/COMPLICATIONS  Liver Diseases/COMPLICATIONS
       Male  Meningitis, Cryptococcal/COMPLICATIONS/*DRUG THERAPY  Middle Age
       Suspensions  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).